Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004131622 | SCV003613499 | uncertain significance | not specified | 2024-05-31 | criteria provided, single submitter | clinical testing | The c.1846G>A (p.G616S) alteration is located in exon 12 (coding exon 11) of the TDRD5 gene. This alteration results from a G to A substitution at nucleotide position 1846, causing the glycine (G) at amino acid position 616 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |